Today's Information |
Provided by: Medigen Vaccine Biologics Corporation | |||||
SEQ_NO | 1 | Date of announcement | 2022/07/01 | Time of announcement | 14:48:06 |
Subject | Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase | ||||
Date of events | 2022/07/01 | To which item it meets | paragraph 53 | ||
Statement | 1.Date of occurrence of the event:2022/07/01 2.Company name:Medigen Vaccine Biologics Corp. 3.Relationship to the Company (please enter "head office" or "subsidiaries"):head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence: Pursuant to "Regulations Governing the Offering and Issuance of Securities by Securities Issuers", hereby announcing. 6.Countermeasures:None 7.Any other matters that need to be specified: (1)The Company issued 7,000,000 shares at NTD 220 per share for the cash capital increase; The total amount of NTD 1,540,000,000 has been fully collected. (2)Reference date of cash capital increase:2022/7/1 (3)Expected listing date:2022/7/6 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medigen Vaccine Biologics Corporation published this content on 01 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2022 06:52:03 UTC.